Pemphigus is a rare autoimmune disease, involving the skin and mucous epithelia, characterized by flaccid blisters and erosions. Histologically, the basic abnormality in all forms of pemphigus is the separation of keratinocytes from one another, a process known as acantholysis. There is direct evidence that autoantibodies against desmoglein, a transmembrane desmosomal component, are critical in its pathogenesis, but the exact mechanism that induces acantholysis is yet unknown. Actually, different studies suggest three possible mechanisms: sterical impedance, intracellular signalling and apoptosis. Understanding these processes should show new therapeutic perspective.
Pemphigus is a rare autoimmune blistering disease involving the skin and mucous epithelia. Clinically, it is characterized by flaccid blisters and erosions and if left untreated could be life-threatening. There are different subtypes of pemphigus. The most important are pemphigus vulgaris (PV) and pemphigus foliaceous (PF). Histologically, PV presents the detachment of suprabasal keratinocytes and a remaining row of cells on the basal membrane with a "tombstone-like" appearance. On the other hand, PF is characterized by the detachment of subcorneal keratinocytes, therefore clinically it is difficult to find intact blisters. The different types of pemphigus always present autoantibodies. In PV they are directed against desmoglein 3 (DSG3), a transmembrane desmosomal component, that belongs to the cadherin superfamily (see Fig. 1 ). It is localized in the basal layer of epidermis and is uniformly present in mucous epithelia. Rarely, in PV there are also autoantibodies against desmoglein I (DSG I), another transmembrane desmosomal component, expressed only in the superficial epidermis. However, the latter autoantibodies are specific to PF and cause a less severe disease. The different antigen targets explain the different clinical presentation. In fact, PV is characterized principally by a mucous involvement, while PF appears just with cutaneous lesions. Moreover, when, in a patient affected by PV, anti-DSG I autoantibodies are also produced, there is a shift from a mucous form to a mucocutaneous form.
Different evidence confirms the essential pathogenic role of autoantibodies. First of all, placental transfer of maternal autoantibodies can induce transient lesions of the disease in newborn babies of women with active pemphigus vulgaris. Studies in vitro have shown that IgG extracted from sera of patients affected by pemphigus can induce acantholysis in cultured human skin (1) and the destruction of epidermal cells (2) . Successively, several authors have provided this evidence in studies in vivo. In a recent study, Amagai et al. have generated a novel experimental murine PV model by transferring splenocytes from a Dsg3-/-mouse, which was immunized with recombinant mouse Dsg3 , to Rag2 -/-immunodeficient mice that normally express Dsg3 . In this way, the model produced anti-Dsg3 IgG. They showed that in this condition mice developed typical mucous and cutaneous lesions (3) . Furthermore, these model mice sho wed a characteristic pemphigus histological feature, with a "tombstone-like" appearance (4). The se result s suggest that IgG have an essential role in the patogenesis of PY. Thu s, pemphigus is an autoimmune blistering disease characterized by the presence of specific IgG antibodies reactive with the outer surface of keratinocytes resulting in acantholysis, but the exact mechanism involved in acantholysis is yet largely unknown. This is an intriguing argument where several research groups show contradictory results.
Several studies have suggested that antiDSG IgG may acti vate intracellular signalling event s. Recentl y, Berkowitz et al. used these autoantibodies in human keratinocytes cell cultures to evaluate the induction of intracellular molecular cascades. They showed that IgG binding to DSG induces p38MAPK and HSP27 phosphorylation and cytoskeletal reorganization (5) . Oth er authors used a passive tran sfer mouse mod el. The y injected anti DSG IgG from PY patients sera to two groups of mice, one pretreated and the other not with inhibitors of proteins that mediate the intracellular signalling cascade. They showed that pretreated mice do not develop acantholysis (6) . The se works support the hypothesi s that, in addition to functioning in cell-78 keralinocyte keratinocyte G. CALDARO LA ET AL.
cell adhesion, desmosomes act as transmembrane receptors transforming external signals in internal signals. Results of this intracellular desmosomal signalling would be a cytoskeletal alteration with an actin reorganization and a keratin retraction, resulting in acantholysis. How ever, recently Shimizu et al. showed that keratin retraction is not the only mechanism of achantolysis. They used post-embedding immunogold EM to evaluate the ultrastructural localization of IgG bind in a passi ve transfer mouse model. Interestingly, they proved that apical and lateral desmosornes ofkeratinocytes have a different fate. In fact, while the latter are degraded by keratin retraction, the former could be split in half without keratin retraction. Moreo ver, they found that, in non-acantholytic areas , anti-DSG3 antibodies bind only the extracellular portion of desmosomes and , in acantholytic sites , desmosomes are separated into two halves and there is no internalisation of splitdesmosomes, therefore they refuse the hypoth esis that DSG3 is depleted from desmo some before acantholysis (7) .
In conclusion, these authors propose that PV IgG induces acantholysis even with a sterical impedance to cellular adhesion. Contrasting with previous studies, other authors minimize the role of antibodies. They base their opinion on the compensation theory by Stanley and Amagai which derives from a study showing that DSG-3 KO mice develop a pemphigus-like disease but afterwards they recover the disfuction with an overexpression of other adhesion molecules; double knock-out mice for both adhesion molecules induce a worse clinical appearance (8) . Moreover, other studies show that most of the local population in geographic areas afflicted by endemicfogo selvageum have circulating IgG to DSG-I without clinical evidence of disease (9) . These data suggest that other factors exist which could induce acantholysis.
Several molecules were investigated because they were thought to be involved in the mechanism of blistering, overall complement and plasminogen. However, most studies show that knock-out mice for these proteins still develop a PV-like disease after a passive transfer experiment (10) (11) . This suggests that both mediators are not fundamental for acantholysis.
The origin of interleukin cascade in pemphigus vulgaris and autoimmune bullous disorders is unknown (12) (13) . There is evidence that epidermal keratinocytes produce chemical mediators which may influence the local immune system in PV and BP. Several authors have looked for a strict association between cytokines and pemphigus, in different ways. Baroni et al. used an immunoenzymatic assay (ELISA) to search IL-IO, IL-8 and IFNy in blister fluid and in patient serum. They found that cytokine level in blister fluid was higher than in sera. Moreover, they suggest an anti-inflammatory role only for IL-IO and a possible role of IL-8 in neutrophil and lymphocyte-monocyte recruitment (14) . Eberhard et al. studied cytokine polymorphisms to evaluate their role in blistering mechanism. They found no differences between pemphigus patients and controls in the frequency of polymorphism of TNFa and TGF~genes. On the contrary, they showed an increased frequency of the low producer IL-IO haplotype, confirming the hypothesis of an antiinflammatory role of this cytokine (15) . Moreover, Toto et al. confirm this data, showing that CD28-deficient mice are more sensitive to the development of pemphigus than wild-type mice, probably because CD-28 deficiency is associated to lower levels ofIL-10 (16) .
Cytokine polymorphisms studies were also included in PF and they showed only a possible pathogenic role for IL-6 (17) (18) . However, the essential role of cytokines is confirmed by an immunohistochemical study that evidences the presence of a T-cell population with a prevalent Th2 cytokine pattern in lesional skin of pemphigus patients, in association with a consistent number of activated granulocytes and mast cells (19) . A similar mechanism is involved, at least in part, in a different blistering disease, pemphigoid (20) .
Cytokines are involved in both expression and modulation of C3, PA and PAl (21) (22) . We have described a role for IL-l a and TNF-u in regulating the expression of C3 and uPA (23) and hypothesise that both cytokines are amplifying factors for acantholysis (24) (25) . In blister fluid and peripheral mononuclear cells of pemphigus patients, prostaglandins (PGE2, PGFI, PGF2), thromboxane B2 and leukotriens (LTB4, LTC4) were also found to be increased (26) (27) (28) .
Briefly, there are two main theories with regard to the mechanism of acantholysis in pemphigus. The first one recognizes IgG bind as the only mediator of acantholysis; the second, on the contrary, postulates an intervention of other factors in addition to the action of antibodies. Recently, a role of apoptosis was proposed in the pathogenesis of acantholysis. At first, Pincelli et al. found high Fas ligand levels in the sera of pemphigus patients. Moreover, they reported that this molecule induced activation of Caspase-8, resulting in apoptosis (29) . Subsequently, Wang et al. showed that in pemphigus vulgaris blisters there are isolated cells and cellular debris with condensed, fragmented nuclei and apoptotic bodies, characteristic of apoptosis. They showed that the apoptotic cells correspond to acantholytic cells and that the apoptosis precedes acantholysis. Further studies demonstrated that anti-DSG and anti-FasR antibodies can induce acantholytic lesions in keratinocytes cultures in a similar way. Both cause: a) secretion of soluble FasL; b) elevated cellular amounts of FasR, FasL (soluble and membranal), Bax and p53 proteins; c) reduction in levels of cellular Bcl-2; d) enrichment in caspase 8, and activation of caspases 1 and 3; e) co-aggregation of FasL and FasR with caspase 8 in membranal deathinducing signaling complex (DISC) (30) .
These results indicated that acantholysis might result from apoptosis induced by cell-surface binding ofPV-IgO, but this hypothesis needs ulterior confirmation. Whilst there are many publications on blister formation, very little is known about re-epithelization and healing in pemphigus. Some authors suggest a role for metalloproteinases (31) (32) while others propose a role for plasminogen activator inhibitor-2 (33) or describe new molecules (34) .
These data taken together suggest that acantholysis is the result of IgO bind. It might act in 3 different ways (see Fig. 2 ). The first one is a simple sterical impedance, thereby a mechanistic way; the second one is a recent report and consists in apoptosis induced by IgO; the third one gives a receptor-like action to desmosomes, hypothesizing acantholysis induced by intracellular molecular cascades. In our opinion these systems act synergycally and are coordinated by cytokines and other chemical mediators expressed by keratinocytes.
